The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia

Author: Griffiths Stephen   Burthem John   Unwin Richard   Holyoake Tessa   Melo Junia   Lucas Guy   Whetton Anthony  

Publisher: Humana Press, Inc

ISSN: 1073-6085

Source: Molecular Biotechnology, Vol.36, Iss.2, 2007-06, pp. : 81-89

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content